Association of Anti-VEGF Therapy with Reported Ocular Adverse Events

This publication has 33 references indexed in Scilit:

• A real-world population-based study on the association between cataracts and antipsychotics
  Canadian Journal of Ophthalmology, 2025
• Drugs Associated With Floppy Iris Syndrome: A Real-World Population-Based Study
  American Journal of Ophthalmology, 2025
• The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
  Drug Safety, 2024
• Severe Intraocular Inflammation Following Intravitreal Faricimab
  JAMA Ophthalmology, 2024
• Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration
  JAMA Ophthalmology, 2020
• Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
  Advances in Therapy, 2019
• Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?
  Clinical Drug Investigation, 2017
• Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration
  Ophthalmology, 2016
• Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
  Ophthalmology, 2012
• Quantitative signal detection using spontaneous ADR reporting
  Pharmacoepidemiology and Drug Safety, 2009